Lupin
Lupin Limited is a transnational pharmaceutical company that focuses on the production and marketing of a diverse range of generic and branded formulations, as well as active pharmaceutical ingredients (APIs). The company is recognized for its significant presence in various therapeutic areas, including Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastrointestinal, and Anti-Infectives. Lupin holds a leading position in the global market for Anti-TB and Cephalosporins. Additionally, it is engaged in the development of specialty products with a robust pipeline in high-barrier markets, including Inhalation, Biosimilars, and Complex Injectables. The majority of Lupin’s sales are generated from the United States, highlighting its strong international footprint in the pharmaceutical sector.
Southern Cross Pharma is a privately owned company providing pharmaceutical products to the Australian and New Zealand markets.
Symbiomix Therapeutics, LLC is a biopharmaceutical company focused on developing innovative treatments for women's health infections, particularly bacterial vaginosis (BV). Founded in 2012 and headquartered in Newark, New Jersey, with additional offices in Baltimore, Maryland, and Hamden, Connecticut, the company specializes in the development of its lead product, Solosec (secnidazole), a next-generation 5-nitroimidazole antibiotic designed for a convenient one-dose treatment. This drug offers enhanced pharmacokinetic properties that improve efficacy and tolerability for patients. Symbiomix is supported by prominent healthcare venture capital firms and aims to address the unmet therapeutic needs in the field of gynecologic infections. Since October 2017, it has operated as a subsidiary of Lupin Inc.
The Temmler Group, with its 7 production sites in Europe, is one of the largest providers of contract services in the pharmaceutical environment. Temmler has a wide experience in formulation development of finished solid, semi-solid and liquid dosage forms, in manufacture, packaging, blinding, distribution and return handling of clinical trial supplies, in the optimization of established manufacturing processes as well as in the contract manufacture of medicinal products with marketing authorization, supplemented by Quality Control and Analytical services. Temmler offers services from stand-alone processes according to customer specifications, to strategic services comprising the entire supply chain.
GAVIS Pharmaceuticals, LLC is a pharmaceutical manufacturer based in Franklin Township, New Jersey, specializing in the sales and distribution of niche drug products. The company offers a diverse range of pharmaceutical formulations, including analgesics, gastric anti-inflammatories, antidepressants, and antifungal medications. GAVIS focuses on providing effective healthcare solutions through its targeted product offerings in the pharmaceutical market.
Novel Laboratories, Inc. is a pharmaceutical company focused on the research, development, and manufacturing of both generic and branded products across various therapeutic classes. The company offers a diverse product portfolio that includes immediate and modified release tablets, capsules, powders, and liquids such as solutions and suspensions. Additionally, they produce topical products like gels, lotions, foams, ointments, and creams, along with respiratory products, vaginal and rectal suppositories, and otic solutions. Novel Laboratories also specializes in injectables, which include lyophilized powders and solutions in various formats, as well as ophthalmic solutions and suspensions. Through its comprehensive range of dosage forms, the company aims to meet the evolving needs of the pharmaceutical market.
JSC Biocom manufactures reproduced pharmaceutical (generic) products in tablet and capsule forms. The company offers agents that affect the hemopoietic system and blood, cardio-vascular system, alimentary system, nervous system, and musculoskeletal system, as well as dermatological and antimicrobial agents. It also offers pharmaceuticalcontract manufacturing services.
Medquímica Indústria Farmacêutica S.A. is a Brazilian pharmaceutical company established in 1975, headquartered in Juiz de Fora, Brazil. The company specializes in developing a wide range of solid and liquid medications, including over-the-counter drugs, generics, and dietary supplements. Medquímica's product offerings also encompass categories such as cardiology, gastroenterology, and hospital pharmaceuticals. The company serves its customers through a network of representatives across Brazil, ensuring broad access to its diverse healthcare solutions. As of May 2015, Medquímica operates as a subsidiary of Lupin Limited.
Pharma Dynamics (Pty) Ltd. operates as a pharmaceutical company. The company offers generic pharmaceuticals; cardiovascular products; central nervous system, pediatric, and over-the-counter products for cold and flu, allergy, heartburn, and immune booster categories; and critical hospital products, such as antibiotics, and male and female specialty healthcare portfolios.
Laboratorios Grin is a pharmaceutical company that manufactures ophthalmological products, antivertiginosis, and oral antibiotics products.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.